Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
- Supplementary File 1:
ZIP-Document (ZIP, 318 KiB)
Gardin, C.; Ferroni, L.; Chachques, J.C.; Zavan, B. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients? J. Clin. Med. 2020, 9, 2762. https://doi.org/10.3390/jcm9092762
Gardin C, Ferroni L, Chachques JC, Zavan B. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients? Journal of Clinical Medicine. 2020; 9(9):2762. https://doi.org/10.3390/jcm9092762
Chicago/Turabian StyleGardin, Chiara, Letizia Ferroni, Juan C. Chachques, and Barbara Zavan. 2020. "Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?" Journal of Clinical Medicine 9, no. 9: 2762. https://doi.org/10.3390/jcm9092762


